Copyright
©The Author(s) 2019.
World J Gastroenterol. Oct 7, 2019; 25(37): 5676-5686
Published online Oct 7, 2019. doi: 10.3748/wjg.v25.i37.5676
Published online Oct 7, 2019. doi: 10.3748/wjg.v25.i37.5676
Figure 1 Study flow chart.
IBD: Inflammatory bowel disease; HBsAg: Hepatitis B surface antigen; HCV: Hepatitis C virus; NAFLD: Nonalcoholic fatty liver disease.
- Citation: Magrì S, Paduano D, Chicco F, Cingolani A, Farris C, Delogu G, Tumbarello F, Lai M, Melis A, Casula L, Fantini MC, Usai P. Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history. World J Gastroenterol 2019; 25(37): 5676-5686
- URL: https://www.wjgnet.com/1007-9327/full/v25/i37/5676.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i37.5676